Inhibition of Usp11 activity, whether genetic (Yan et al., 2022) or drug-induced (Guo et al., 2024), led to a decrease in pTau, Aβ42 burden and an increase in synaptic plasticity and spatial memory in transgenic mouse models of AD, particularly in females. Here, USP11 is linked to Alzheimer disease.